Centragard is a drug owned by BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC. It is protected by 1 US drug patent filed in 2039. All patents are active. Details of Centragard’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US11583545 | Active | |
Exclusivity Information
Centragard holds 1 exclusivity out of which 1 has expired. Details of Centragard's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Mar 08, 2021 |
About Centragard
Centragard is a drug
owned by BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC.
Centragard uses
Eprinomectin, Praziquantel as the active
ingredients.
Active Ingredient:
Centragard uses
Eprinomectin,
Praziquantel
as the active ingredients.
Check out other Drugs and Companies using
Eprinomectin, Praziquantel ingredient.